Loading…
Assessment of epinephrine sublingual stability and permeability pathways to enhance its permeability for the treatment of anaphylaxis
[Display omitted] Prompt epinephrine (Epi) injection using auto-injectors is the initial life-saving out-of-hospital treatment for anaphylaxis. However, patients and healthcare providers are eagerly awaiting a more convenient alternative dosage form that would overcome auto-injectors drawbacks. Prev...
Saved in:
Published in: | European journal of pharmaceutical sciences 2021-12, Vol.167, p.106025-106025, Article 106025 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c333t-ff3c8be308704c9f883207ccb327db00e8fed526f92fc9c28386cca083520bf63 |
---|---|
cites | cdi_FETCH-LOGICAL-c333t-ff3c8be308704c9f883207ccb327db00e8fed526f92fc9c28386cca083520bf63 |
container_end_page | 106025 |
container_issue | |
container_start_page | 106025 |
container_title | European journal of pharmaceutical sciences |
container_volume | 167 |
creator | Rawas-Qalaji, Mutasem Bafail, Rawan Cagliani, Roberta Haider, Mohamed Hussain, Zahid |
description | [Display omitted]
Prompt epinephrine (Epi) injection using auto-injectors is the initial life-saving out-of-hospital treatment for anaphylaxis. However, patients and healthcare providers are eagerly awaiting a more convenient alternative dosage form that would overcome auto-injectors drawbacks.
Previously, we extensively evaluated multiple alternative fast-disintegrating sublingual Epi tablet (FDSTs) formulations. However, the sublingual stability of Epi and effect of modifying the sublingual microenvironment pH on its stability and transport pathways were not yet fully investigated.
Results depicted that Epi remained sufficiently stable at various pHs in human saliva and porcine sublingual tissue's extract. Epi permeability (EP) through excised porcine sublingual membrane was greatest at pH 8.0 (p 5 min). Meanwhile, Na Carb and SDS combination increased EP 23-fold without a delay.
It is evident that pH-modifiers or their SDS combination showed promising potential to enhance Epi sublingual permeability and further reduce the required Epi dose using FDSTs as a feasible alternative to Epi auto-injectors. |
doi_str_mv | 10.1016/j.ejps.2021.106025 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2578769202</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928098721003286</els_id><sourcerecordid>2578769202</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-ff3c8be308704c9f883207ccb327db00e8fed526f92fc9c28386cca083520bf63</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EEqXwA6y8ZJMysWniSGyqipdUiQ2sLccZE1dpEjwukA_gv0lVumDDZka6unceh7HLFGYppNn1eobrnmYCRDoKGYj5EZukKi8SyAUcswkUQiVQqPyUnRGtASBTOUzY94IIiTbYRt45jr1vsa_DWDlty8a3b1vTcIqm9I2PAzdtxXsMGzwIvYn1pxmIx45jW5vWIveR_ppcF3iskceAJh52mdb09dCYL0_n7MSZhvDit0_Z6_3dy_IxWT0_PC0Xq8RKKWPinLSqRAnj6Te2cEpJAbm1pRR5VQKgcljNReYK4WxhhZIqs9aAknMBpcvklF3t5_ahe98iRb3xZLFpTIvdlrSY5yrPihHjaBV7qw0dUUCn--A3Jgw6Bb1jrtd6x1zvmOs98zF0uw_h-MSHx6DJehyRVD6gjbrq_H_xHylnjpM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2578769202</pqid></control><display><type>article</type><title>Assessment of epinephrine sublingual stability and permeability pathways to enhance its permeability for the treatment of anaphylaxis</title><source>Elsevier</source><creator>Rawas-Qalaji, Mutasem ; Bafail, Rawan ; Cagliani, Roberta ; Haider, Mohamed ; Hussain, Zahid</creator><creatorcontrib>Rawas-Qalaji, Mutasem ; Bafail, Rawan ; Cagliani, Roberta ; Haider, Mohamed ; Hussain, Zahid</creatorcontrib><description>[Display omitted]
Prompt epinephrine (Epi) injection using auto-injectors is the initial life-saving out-of-hospital treatment for anaphylaxis. However, patients and healthcare providers are eagerly awaiting a more convenient alternative dosage form that would overcome auto-injectors drawbacks.
Previously, we extensively evaluated multiple alternative fast-disintegrating sublingual Epi tablet (FDSTs) formulations. However, the sublingual stability of Epi and effect of modifying the sublingual microenvironment pH on its stability and transport pathways were not yet fully investigated.
Results depicted that Epi remained sufficiently stable at various pHs in human saliva and porcine sublingual tissue's extract. Epi permeability (EP) through excised porcine sublingual membrane was greatest at pH 8.0 (p < 0.05), 11-fold higher than the negative control (Epi at pH 6.8). Sodium carbonate (Na Carb) 0.75% was the most efficient buffer to modify Epi solution pH to 8.0. Both sodium dodecyl sulfate (SDS) 0.075% and palmitoyl-DL-carnitine chloride (PCC) 1.2% increased paracellular EP 10-fold and 3-fold, respectively; however, both demonstrated a delayed enhancement (>5 min). Meanwhile, Na Carb and SDS combination increased EP 23-fold without a delay.
It is evident that pH-modifiers or their SDS combination showed promising potential to enhance Epi sublingual permeability and further reduce the required Epi dose using FDSTs as a feasible alternative to Epi auto-injectors.</description><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><identifier>DOI: 10.1016/j.ejps.2021.106025</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Anaphylaxis ; Epinephrine ; Fast disintegrating tablets ; Permeability ; Stability ; Sublingual</subject><ispartof>European journal of pharmaceutical sciences, 2021-12, Vol.167, p.106025-106025, Article 106025</ispartof><rights>2021 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c333t-ff3c8be308704c9f883207ccb327db00e8fed526f92fc9c28386cca083520bf63</citedby><cites>FETCH-LOGICAL-c333t-ff3c8be308704c9f883207ccb327db00e8fed526f92fc9c28386cca083520bf63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids></links><search><creatorcontrib>Rawas-Qalaji, Mutasem</creatorcontrib><creatorcontrib>Bafail, Rawan</creatorcontrib><creatorcontrib>Cagliani, Roberta</creatorcontrib><creatorcontrib>Haider, Mohamed</creatorcontrib><creatorcontrib>Hussain, Zahid</creatorcontrib><title>Assessment of epinephrine sublingual stability and permeability pathways to enhance its permeability for the treatment of anaphylaxis</title><title>European journal of pharmaceutical sciences</title><description>[Display omitted]
Prompt epinephrine (Epi) injection using auto-injectors is the initial life-saving out-of-hospital treatment for anaphylaxis. However, patients and healthcare providers are eagerly awaiting a more convenient alternative dosage form that would overcome auto-injectors drawbacks.
Previously, we extensively evaluated multiple alternative fast-disintegrating sublingual Epi tablet (FDSTs) formulations. However, the sublingual stability of Epi and effect of modifying the sublingual microenvironment pH on its stability and transport pathways were not yet fully investigated.
Results depicted that Epi remained sufficiently stable at various pHs in human saliva and porcine sublingual tissue's extract. Epi permeability (EP) through excised porcine sublingual membrane was greatest at pH 8.0 (p < 0.05), 11-fold higher than the negative control (Epi at pH 6.8). Sodium carbonate (Na Carb) 0.75% was the most efficient buffer to modify Epi solution pH to 8.0. Both sodium dodecyl sulfate (SDS) 0.075% and palmitoyl-DL-carnitine chloride (PCC) 1.2% increased paracellular EP 10-fold and 3-fold, respectively; however, both demonstrated a delayed enhancement (>5 min). Meanwhile, Na Carb and SDS combination increased EP 23-fold without a delay.
It is evident that pH-modifiers or their SDS combination showed promising potential to enhance Epi sublingual permeability and further reduce the required Epi dose using FDSTs as a feasible alternative to Epi auto-injectors.</description><subject>Anaphylaxis</subject><subject>Epinephrine</subject><subject>Fast disintegrating tablets</subject><subject>Permeability</subject><subject>Stability</subject><subject>Sublingual</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EEqXwA6y8ZJMysWniSGyqipdUiQ2sLccZE1dpEjwukA_gv0lVumDDZka6unceh7HLFGYppNn1eobrnmYCRDoKGYj5EZukKi8SyAUcswkUQiVQqPyUnRGtASBTOUzY94IIiTbYRt45jr1vsa_DWDlty8a3b1vTcIqm9I2PAzdtxXsMGzwIvYn1pxmIx45jW5vWIveR_ppcF3iskceAJh52mdb09dCYL0_n7MSZhvDit0_Z6_3dy_IxWT0_PC0Xq8RKKWPinLSqRAnj6Te2cEpJAbm1pRR5VQKgcljNReYK4WxhhZIqs9aAknMBpcvklF3t5_ahe98iRb3xZLFpTIvdlrSY5yrPihHjaBV7qw0dUUCn--A3Jgw6Bb1jrtd6x1zvmOs98zF0uw_h-MSHx6DJehyRVD6gjbrq_H_xHylnjpM</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Rawas-Qalaji, Mutasem</creator><creator>Bafail, Rawan</creator><creator>Cagliani, Roberta</creator><creator>Haider, Mohamed</creator><creator>Hussain, Zahid</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20211201</creationdate><title>Assessment of epinephrine sublingual stability and permeability pathways to enhance its permeability for the treatment of anaphylaxis</title><author>Rawas-Qalaji, Mutasem ; Bafail, Rawan ; Cagliani, Roberta ; Haider, Mohamed ; Hussain, Zahid</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-ff3c8be308704c9f883207ccb327db00e8fed526f92fc9c28386cca083520bf63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anaphylaxis</topic><topic>Epinephrine</topic><topic>Fast disintegrating tablets</topic><topic>Permeability</topic><topic>Stability</topic><topic>Sublingual</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rawas-Qalaji, Mutasem</creatorcontrib><creatorcontrib>Bafail, Rawan</creatorcontrib><creatorcontrib>Cagliani, Roberta</creatorcontrib><creatorcontrib>Haider, Mohamed</creatorcontrib><creatorcontrib>Hussain, Zahid</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rawas-Qalaji, Mutasem</au><au>Bafail, Rawan</au><au>Cagliani, Roberta</au><au>Haider, Mohamed</au><au>Hussain, Zahid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of epinephrine sublingual stability and permeability pathways to enhance its permeability for the treatment of anaphylaxis</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><date>2021-12-01</date><risdate>2021</risdate><volume>167</volume><spage>106025</spage><epage>106025</epage><pages>106025-106025</pages><artnum>106025</artnum><issn>0928-0987</issn><eissn>1879-0720</eissn><abstract>[Display omitted]
Prompt epinephrine (Epi) injection using auto-injectors is the initial life-saving out-of-hospital treatment for anaphylaxis. However, patients and healthcare providers are eagerly awaiting a more convenient alternative dosage form that would overcome auto-injectors drawbacks.
Previously, we extensively evaluated multiple alternative fast-disintegrating sublingual Epi tablet (FDSTs) formulations. However, the sublingual stability of Epi and effect of modifying the sublingual microenvironment pH on its stability and transport pathways were not yet fully investigated.
Results depicted that Epi remained sufficiently stable at various pHs in human saliva and porcine sublingual tissue's extract. Epi permeability (EP) through excised porcine sublingual membrane was greatest at pH 8.0 (p < 0.05), 11-fold higher than the negative control (Epi at pH 6.8). Sodium carbonate (Na Carb) 0.75% was the most efficient buffer to modify Epi solution pH to 8.0. Both sodium dodecyl sulfate (SDS) 0.075% and palmitoyl-DL-carnitine chloride (PCC) 1.2% increased paracellular EP 10-fold and 3-fold, respectively; however, both demonstrated a delayed enhancement (>5 min). Meanwhile, Na Carb and SDS combination increased EP 23-fold without a delay.
It is evident that pH-modifiers or their SDS combination showed promising potential to enhance Epi sublingual permeability and further reduce the required Epi dose using FDSTs as a feasible alternative to Epi auto-injectors.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.ejps.2021.106025</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0928-0987 |
ispartof | European journal of pharmaceutical sciences, 2021-12, Vol.167, p.106025-106025, Article 106025 |
issn | 0928-0987 1879-0720 |
language | eng |
recordid | cdi_proquest_miscellaneous_2578769202 |
source | Elsevier |
subjects | Anaphylaxis Epinephrine Fast disintegrating tablets Permeability Stability Sublingual |
title | Assessment of epinephrine sublingual stability and permeability pathways to enhance its permeability for the treatment of anaphylaxis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T14%3A36%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20epinephrine%20sublingual%20stability%20and%20permeability%20pathways%20to%20enhance%20its%20permeability%20for%20the%20treatment%20of%20anaphylaxis&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=Rawas-Qalaji,%20Mutasem&rft.date=2021-12-01&rft.volume=167&rft.spage=106025&rft.epage=106025&rft.pages=106025-106025&rft.artnum=106025&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/10.1016/j.ejps.2021.106025&rft_dat=%3Cproquest_cross%3E2578769202%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c333t-ff3c8be308704c9f883207ccb327db00e8fed526f92fc9c28386cca083520bf63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2578769202&rft_id=info:pmid/&rfr_iscdi=true |